These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31607702)

  • 1. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
    Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
    Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
    Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC
    PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO; Sanders K; Abreo FW; Nassar R; Glass J
    Cancer Res; 2000 Jul; 60(13):3599-604. PubMed ID: 10910074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
    Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
    Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
    Abouhashem NS; Elwan A; Elaidy NF
    Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
    J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
    BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
    Mohan S; Pai SI; Bhattacharyya N
    Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study.
    Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Kreppel M; Zöller J; Fridman E; Bolzoni VA; Shah JP; Binenbaum Y; Patel SG; Gil Z;
    Cancer; 2013 Dec; 119(24):4242-8. PubMed ID: 24114787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
    Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
    Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
    Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.
    Chen AM; Yu Y; Daly ME; Farwell DG; Benedict SH; Purdy JA
    Head Neck; 2014 Dec; 36(12):1766-72. PubMed ID: 24174221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of p53 over-expression in the outcome with radiation in head and neck cancers.
    Lal P; Pal L; Kumar S; Dimri K; Tiwari A; Rastogi N; Singh S; Datta NR
    J Cancer Res Ther; 2007; 3(1):17-22. PubMed ID: 17998714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.